IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improving treatment of acute myocardial infarction (AMI), announced that the U.S. Food and Drug ...

ROYAL OAK -- Over the past two decades, cardiologists have explored many different treatments to help prevent permanent heart damage after a heart attack. One treatment that appears to be very ...

SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...

IRVINE, Calif.--(BUSINESS WIRE)--TherOx, a ZOLL ® Medical company, announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO 2) Therapy at the upcoming Transcatheter ...

Results of a clinical trial demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening ...

Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of "widowmaker" heart ...

CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...

A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company, has been selected to exhibit SuperSaturated Oxygen (SSO 2) Therapy, which delivers high levels of dissolved oxygen directly to the ...

ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination ...